SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dlawdude who wrote (313)12/23/2004 10:56:09 AM
From: dlawdude  Read Replies (1) of 371
 
Ive heard nothing besides the rumors posted - the company indicated that they are still proceeding with PAM4 and AFP trials which are in Phase I/II but enrollment seems to be very slow. Its sort of frustrating since Cindy indicated in Conference last spring that the company was working on 4 deals. Now all we hear are rumors about the Emab deal involving Lupus - and who knows when that will go through - the company needs to make a deal before June or it will have to sell more shares - I'm concerned they will hold out for more money in a deal and end up further diluting the stock.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News